In addition, metabolic assessment (blood glucose, insulin levels, insulin resistance (via the homeostatic model assessment of insulin resistance) and lipid profile) should also be conducted in all children with suspected or diagnosed NAFLD. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.